Austin D. Williams, MD, MSEd

Austin D. Williams, MD, MSEd, a surgeon in breast cancer and an assistant professor in the Department of Surgical Oncology
​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Assistant Professor, Department of Surgical Oncology

Specialties

Treatment Focus

  • Breast cancer surgery including:
    • Breast conservation
    • Skin-sparing mastectomy
    • Nipple-sparing mastectomy
    • Aesthetic flat closure after mastectomy
  • High-risk patients and risk-reducing surgery
  • Male breast cancer
  • LGBTQ+ health
  • Breast cancer clinical trials

Key Awards

•    Top Physicians Under 40 - Pennsylvania Medical Society, 2023
•    Emerging Leader Award - Drexel University College of Medicine, 2023
•    Best Scientific Poster Award - American Society of Breast Surgeons, 2023
 

Treatment Philosophy

I count it as a privilege to be able to devote my surgical practice exclusively to the care of patients with breast cancer, collaborating with the remarkable multidisciplinary team at Fox Chase Cancer Center to provide world-class breast cancer care. 

A diagnosis of breast cancer can be incredibly frightening, but from the very first consultation, I make it a priority to show patients that there is a path forward, and that the advances in care for breast cancer may make their journey through treatment and into survivorship easier than they are anticipating. As a former high school teacher, I also view every patient encounter as an opportunity to educate. I consider it to be my responsibility that patients and their loved ones understand their diagnosis and each of their treatment options, spending as much time as necessary to ensure they are equipped to make decisions that are right for them. 

I also approach the treatment of breast cancer as a researcher, constantly evaluating whether we can improve aspects of our treatment strategies. Whether it is attempting to understand and dismantle barriers to patient access to high quality care, studying whether we can de-escalate the amount of surgery we perform, or probing the inner workings of a patient’s specific tumor cells, I am committed to delivering the most innovative and cutting-edge breast cancer care to each of my patients.

Clinical Locations

Educational Background

  • Fellow, Breast Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 2021-2022
  • Resident, General Surgery, Lankenau Medical Center, Wynnewood, PA, 2014-2021
  • Post-doctoral Research Fellow, Hospital of the University of Pennsylvania, Philadelphia, PA, 2016-2018
  • MD, Drexel University College of Medicine, Philadelphia, PA, 2009-2013
  • Master's in Education, University of Pennsylvania, Philadelphia, PA, 2007-2009
  • BA, Franklin & Marshall College, Lancaster, PA, 2003-2007

Certifications

American Board of Surgery

Memberships

  • Society of Surgical Oncology
    • Member, Fellows-Young Attendings Subcommittee, 2021-present
    • Annals of Surgical Oncology Social Media Committee, 2022-present
  • American Society of Breast Surgeons
    • Member, Breast Fellows Working Group, 2021-present
  • American Society of Clinical Oncology
  • American College of Surgeons
    • Associate Fellow and Resident Representative, Metropolitan Philadelphia Chapter, 2022-present
  • Association of Academic Surgery
  • Association for Surgical Education
  • Gay and Lesbian Medical Association
  • Pennsylvania Medical Society
  • Male Breast Cancer Global Alliance
    • Member, Medical and Scientific Advisory Council, 2022-present

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2023-2024
  • Emerging Leader Award, Drexel University College of Medicine, 2023
  • Kroll Family Fellowship, Memorial Sloan Kettering Cancer Center, 2021-2022
  • Administrative Chief Resident, Department of Surgery, Lankenau Medical Center, 2020-2021
  • Outstanding Scientific Presentation Award, American Society of Breast Surgeons, 2018
  • Owen H. Wangasteen Excellence in Research Award, American College of Surgeons, 2017
  • Surgical Education Research Fellowship, Association for Surgical Education, 2017
  • Anna Elizabeth Fleer Surgery Research Award, Department of Surgery, Lankenau Medical Center, 2015, 2016, 2018
  • Excellence in Medical Student Teaching Award, Department of Surgery, Lankenau Medical Center, 2015
  • G.C. Engel Intern of the Year Award, Department of Surgery, Lankenau Medical Center, 2015
  • Dean’s Award in Medical Humanities, Drexel University College of Medicine, 2013
  • Lindback Foundation Award for Distinguished High School Educators, School District of Philadelphia, 2008
  • Michelle Kayal Memorial Scholarship Research Award, Franklin & Marshall College, 2007

Research Interests

  • Breast cancer clinical trials
  • Surgical management after neoadjuvant therapy
  • Reducing breast cancer disparities
  • High-risk patients
  • Male breast cancer
  • LGBTQ+ health
  • Surgical education
Lisa Shustack

Lisa Shustack

  • Breast Cancer

A few years ago, when I was 46, something unusual showed up on my yearly mammogram. So they did an ultrasound and said I should come back every six months for monitoring for the next two years.

For 18 months, there was no change. Then, in April of 2023, I went for my last follow-up scan. When we finished, instead of sending me home, the radiologist came into the room to talk to me. I knew then that something wasn’t right.

She said there had been a change since my last scan. It looked like I had a malignancy in my right breast, and we would need a biopsy to be sure.

VIEW PATIENT STORY

Selected Publications

Williams, A.D., Khan, A.J., Sevilimedu, V., Barrio, A.V., Morrow, M., Mamtani, A. Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy. Ann Surg Onc. ePub Aug 2022.

Williams, A.D., Dang, C.T., Sevilimedu, V., Morrow, M., Barrio, A.V. Neoadjuvant chemotherapy for breast cancer in the elderly: are we accomplishing our treatment goals? Ann Surg Onc. ePub Jul 2022.

Williams, A.D., Ciocca, R.M., Sabol, J.L., Carp, N.Z. The use of neoadjuvant therapy increases the rate of breast conservation in men with locally advanced breast cancer. Clinical Breast Cancer. Jun 2022. 22(4):343-358.

Williams, A.D., Chang, C., Wang, C., Sigurdson, E.R., Aggon, A.A., Porpiglia, A., Hill, M.V., Bleicher, R.J. Neoadjuvant endocrine therapy and delays in surgery for ductal carcinoma in situ: implications for the coronavirus pandemic. Ann Surg Onc. Mar 2022. 29(3):1683–1691.

Williams, A.D., Buckley, M., Ciocca, R.M., Sabol, J.L., Larson, S.L., Carp, N.Z. Racial and Economic Disparities in Breast Cancer Incidence and Mortality in Pennsylvania. Breast Cancer Res Treat. Feb 2022. 192:191–200.

Williams, A.D., Ciocca, R.M., Sabol, J.L., Carp, N.Z. Institutions treating breast cancer patients of a low socioeconomic status achieve multidisciplinary quality standards at lower rates. Ann Surg Onc. Oct 2021. 28(10):5635-5647.

Williams, A.D., McGreevy, C., Tchou, J., De La Cruz, L. Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration- A Comparative Study with Female Patients. Ann Surg Onc. Oct 2020. 27(10):3605-3611.

Williams, A.D., Bleicher, R., Ciocca, R. Breast cancer risk, screening and prevalence among sexual minority women: an analysis of the National Health Interview Survey. LGBT Health. Feb/Mar 2020. 7(2):109-118.

Williams, A.D., Arlow, R., Reyes, S., Tchou, J., De La Cruz, L. Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients <50 versus ≥50 and Trends Over Time. Ann Surg Onc. Oct 2018. 25(10):2875-2883.

Williams, A.D., So A., Synnestvedt M., Tewksbury C.M., Kontos D., Hsieh M.K., Pantalone L., Conant E.F., Schnall M., Dumon K., Williams N., Tchou J. Mammographic breast density decreases after bariatric surgery. Breast Cancer Res Treat. Oct 2017. 165(3):565-572.

Additional Publications

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​